← FDA Drug Approvals (Drugs@FDA)
DILTIAZEM HYDROCHLORIDE IN 0.72% SODIUM CHLORIDE
NDA · New Drug Application · Sponsor: HQ SPCLT PHARMA · Approved 2025-02-21
Drug application
- FDA Application #
NDA218038- Application type
- New Drug Application
- Brand name
- DILTIAZEM HYDROCHLORIDE IN 0.72% SODIUM CHLORIDE
- Generic name
- DILTIAZEM HYDROCHLORIDE
- Active ingredients
- DILTIAZEM HYDROCHLORIDE
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Sponsor
- HQ SPCLT PHARMA
- Manufacturer
- WG Critical Care, LLC
- First approval
- 2025-02-21
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown